Back to Faculty
Faculty

Sara Nunnery

MD, MSCI
Director of Breast Cancer Research
Tennessee Oncology

2026 Sessions

Advancing Precision Care in HR+/HER2- Metastatic Breast Cancer: ESR1 Testing and the Expanding Role of Oral SERDs

Supported by educational grants from AstraZeneca and Stemline Therapeutics Inc, a Menarini Company.

Presenter

Sunday, March 15 11:10–11:55 AM
Room Royal Ballroom 1
Breast Cancers
Faculty

Sara Nunnery

MD, MSCI
Director of Breast Cancer Research
Tennessee Oncology

Advancing Precision Care in HR+/HER2- Metastatic Breast Cancer: ESR1 Testing and the Expanding Role of Oral SERDs

Supported by educational grants from AstraZeneca and Stemline Therapeutics Inc, a Menarini Company.

Presenter

Sunday, September 27 10:50–11:35 AM
Breast Cancers
Faculty

Sara Nunnery

MD, MSCI
Director of Breast Cancer Research
Tennessee Oncology
Back to top